Identification and characterization of calcifying valve cells from human and canine aortic valves

Journal of Heart Valve Disease

Volumn 8, Issue 3, 1999, Pages 254-260

  Mohler III, Emile R ^a,d   Chawla, Mohit K ^b   Chang, Alan W ^a   Vyavahare, Narendra ^c   Levy, Robert J ^c   Graham, Lori ^b   Gannon, Francis H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b INDIANA UNIVERSITY   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d PENN PRESBYTERIAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYCHOLESTEROL; BONE MORPHOGENETIC PROTEIN 2; HYDROXYAPATITE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL TISSUE; AORTA VALVE; AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; ARTICLE; CALCIFICATION; CELL DIFFERENTIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL;

EID: 0033057678     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Monckeberg JG. Der normale histologische Bau und die Sklerose der Aortenklappen. Virchows Arch Pathol Anat Physiol 1904;176:472-514
2. Edwards JE. On the etiology of calcific aortic stenosis. Circulation 1962;26:17-18
3. Mohler ER, Adam LP, McClelland P, Graham L, Hath-away DR. Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vase Biol 1997;17:547-552
4. O'Brien KD, Kuusisto J, Reichenbach DD, et al. Osteo-pontin is expressed in human aortic valvular lesions. Circulation 1995;92:2163-2168
5. Srivatsa SS, Harrity PJ, Maercklein PB, et al. Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves. J Clin Invest 1997;99:996-1009
6. Mohler ER, Cannon FH, Reynolds C, Kaplan FS. Bone formation and osteoclast remodeling in calcified cardiac valves: A clinical and pathologic analysis. J Am Coll Cardiol 1998;31:503A (abstract)
7. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of 'degenerative' valvular aortic stenosis: Histological and immunohistochemical studies. Circulation 1994;90:844-853
8. Bostrom K, Watson KE, Horn S, Worthham C, Herman IM, Demer LL. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1994;91:1800-1809
9. Watson KE, Bostrom K, Ravindranath R, Lam T, Norton B, Demer LL. TGF-β1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 1994;93:2106-2113
10. Guesdon JL, Ternynck T, Avrameas S. The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 1979;27:1131-1139
11. Gimbrone MAJ, Cotran RS. Human vascular smooth muscle in culture. Growth and ultrastructure. Lab Invest 1975;33:16-27
12. Bjorkerud S, Bjorkerud B, Joelsson M. Structural organization of reconstituted human arterial smooth muscle tissue. Arterioscler Thromb 1994;14:644-651
13. Bjorkerud S. Agglomeration to nodules modulates human arterial smooth muscle cells to distinct postinjury phenotype via foam cell transition. Am J Pathol 1987;127:485-498
14. May JF, Wendelin JP, Rounds DE, Blankenhorn DH, Zemplenyi T. The induction of atherosclerotic plaque-like mounds in cultures of aortic smooth muscle cells. Virchows Arch B Cell Pathol 1975;18:205-211
15. Kim KM. Cell death and calcification of canine fibroblasts in vitro. Cells Mater 1994;4:247-261
16. Ingram RT, Bonde SK, Riggs BL, Fitzpatrick LA. Effects of transforming growth factor beta (TGF beta) and 1,25 dihydroxyvitamin D3 on the function, cytochemistry and morphology of normal human osteoblast-like cells. Differentiation 1994;55:153-163
17. Parhami F, Morrow AD, Balucan J, et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vase Biol 1997;17:680-687